SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-063863
Filing Date
2010-11-29
Accepted
2010-11-29 17:05:18
Documents
9
Period of Report
2010-08-31

Document Format Files

Seq Description Document Type Size
1 v204045_10k.htm 10-K 1719353
2 v204045_ex23-1.htm EX-23.1 5636
3 GRAPHIC ex231logo.jpg GRAPHIC 19620
4 v204045_ex23-2.htm EX-23.2 3877
5 GRAPHIC footer.jpg GRAPHIC 47790
6 GRAPHIC mb_logo.jpg GRAPHIC 21763
7 v204045_ex31-1.htm EX-31.1 10950
8 v204045_ex31-2.htm EX-31.2 10957
9 v204045_ex32-1.htm EX-32.1 7629
  Complete submission text file 0001144204-10-063863.txt   1883273
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-50298 | Film No.: 101219553
SIC: 2834 Pharmaceutical Preparations